mywealthgrid
Overview
Dashboard
My workspace
My PortfolioWatchlistsFollowingScreenersAlertsResearch
Discover
CompaniesSectorsIndicesMutual fundsInstitutional investorsCompareTrade trends
Market updates
ResultsAnnouncementsSearch filingsCalendarUpcoming listings
Sign in to save your work
Sign inSign up
Loading page…
AB

Avience Biomedicals Limited

NSE:AVIENCESME
UnclassifiedUnclassified
₹323.8
-9.99%1 Oct close
Mkt cap
—
Watch Alert Compare
OverviewChartPeersProfit & lossBalance sheetCash flowRatiosShareholdingF&ODocumentsEventsAnnouncementsNotes
ConsolidatedStandalone

Consolidated figures

RatioMar 2024Mar 2025Mar 2026
Margins
Gross margin %43.9%47.5%45.1%
EBITDA margin %14.4%23.3%28.5%
EBIT margin %
14.4%
23.3%
26.1%
PAT margin %8.9%16%16.7%
Working capital
Receivable days123139—
Inventory days337201218
Payable days———
NWC days———
Leverage
Current ratio4.760.051.46
Debt to EBITDA4.392.1—
Debt to equity2.440.97—
Interest coverage4.27.69.1
Asset turnover0.690.80.7
Return ratios
Return on assets %6.2%12.8%11.7%
Return on capital employed %12.7%28%29.4%
Return on equity %34.5%31.7%—

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.